|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 April 2002, Vol. 99, No. 8, pp. 2801-2809
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Differential catalytic properties and vascular topography of
murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and
NTPDase2 have implications for thromboregulation
Jean Sévigny,
Christian Sundberg,
Norbert Braun,
Olaf Guckelberger,
Eva Csizmadia,
Imrana Qawi,
Masato Imai,
Herbert Zimmermann, and
Simon C. Robson
From the Departments of Medicine and Pathology, Beth
Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;
Centre de recherche en Rhumatologie et Immunologie CHUQ,
Université Laval, Sainte-Foy, Québec, Canada; and
Biozentrum der JW Goethe-Universität, AK Neurochemie,
Zoologisches Institut, Frankfurt am Main, Germany.
Nucleoside triphosphate diphosphohydrolases (NTPDases) are a
recently described family of ectonucleotidases that differentially hydrolyze the  and  phosphate residues of extracellular
nucleotides. Expression of this enzymatic activity has the potential to
influence nucleotide P2 receptor signaling within the vasculature. We
and others have documented that NTPDase1 (CD39, 78 kd) hydrolyzes both
triphosphonucleosides and diphosphonucleosides and thereby terminates
platelet aggregation responses to adenosine diphosphate (ADP). In
contrast, we now show that NTPDase2 (CD39L1, 75 kd), a preferential
nucleoside triphosphatase, activates platelet aggregation by converting
adenosine triphosphate (ATP) to ADP, the specific agonist of
P2Y1 and P2Y12 receptors. We developed
specific antibodies to murine NTPDase1 and NTPDase2 and
observed that both enzymes are present in the cardiac vasculature;
NTPDase1 is expressed by endothelium, endocardium, and to a
lesser extent by vascular smooth muscle, while NTPDase2 is associated
with the adventitia of muscularized vessels, microvascular pericytes,
and other cell populations in the subendocardial space. Moreover,
NTPDase2 represents a novel marker for microvascular pericytes.
Differential expression of NTPDases in the vasculature suggests
spatial regulation of nucleotide-mediated signaling. In this
context, NTPDase1 should abrogate platelet aggregation and recruitment
in intact vessels by the conversion of ADP to adenosine monophosphate,
while NTPDase2 expression would promote platelet microthrombus
formation at sites of extravasation following vessel injury. Our data
suggest that specific NTPDases, in tandem with ecto-5'-nucleotidase,
not only terminate P2 receptor activation and trigger adenosine
receptors but may also allow preferential activation of
specific subsets of P2 receptors sensitive to ADP (eg,
P2Y1, P2Y3, P2Y12) and uridine diphosphate (P2Y6).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
G. Kauffenstein, A. Drouin, N. Thorin-Trescases, H. Bachelard, B. Robaye, P. D'Orleans-Juste, F. Marceau, E. Thorin, and J. Sevigny
NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse
Cardiovasc Res,
August 20, 2009;
(2009)
cvp265v2.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Friedman, M. E. Talbert, D. W. Bowden, B. I. Freedman, Y. Mukanya, K. Enjyoji, and S. C. Robson
Functional ENTPD1 Polymorphisms in African Americans With Diabetes and End-Stage Renal Disease
Diabetes,
April 1, 2009;
58(4):
999 - 1006.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Corriden, Y. Chen, Y. Inoue, G. Beldi, S. C. Robson, P. A. Insel, and W. G. Junger
Ecto-nucleoside Triphosphate Diphosphohydrolase 1 (E-NTPDase1/CD39) Regulates Neutrophil Chemotaxis by Hydrolyzing Released ATP to Adenosine
J. Biol. Chem.,
October 17, 2008;
283(42):
28480 - 28486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Yu, E. G. Lavoie, N. Sheung, J. J. Tremblay, J. Sevigny, and J. A. Dranoff
IL-6 downregulates transcription of NTPDase2 via specific promoter elements
Am J Physiol Gastrointest Liver Physiol,
March 1, 2008;
294(3):
G748 - G756.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Vallon
P2 receptors in the regulation of renal transport mechanisms
Am J Physiol Renal Physiol,
January 1, 2008;
294(1):
F10 - F27.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Friedman, H. G. Rennke, E. Csizmadia, K. Enjyoji, and S. C. Robson
The Vascular Ectonucleotidase ENTPD1 Is a Novel Renoprotective Factor in Diabetic Nephropathy
Diabetes,
September 1, 2007;
56(9):
2371 - 2379.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Borsellino, M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Hopner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, et al.
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression
Blood,
August 15, 2007;
110(4):
1225 - 1232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Dieterich, C. von Klitzing, and A. Deussen
Relative importance of mechanisms needs clarification
FASEB J,
July 1, 2007;
21(9):
1951 - 1952.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Deaglio, K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J.-F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al.
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
J. Exp. Med.,
June 11, 2007;
204(6):
1257 - 1265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Fausther, J. Lecka, F. Kukulski, S. A. Levesque, J. Pelletier, H. Zimmermann, J. A. Dranoff, and J. Sevigny
Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8
Am J Physiol Gastrointest Liver Physiol,
March 1, 2007;
292(3):
G785 - G795.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. M. Kunzli, P. O. Berberat, T. Giese, E. Csizmadia, E. Kaczmarek, C. Baker, I. Halaceli, M. W. Buchler, H. Friess, and S. C. Robson
Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease
Am J Physiol Gastrointest Liver Physiol,
January 1, 2007;
292(1):
G223 - G230.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Gunduz, S. A. Kasseckert, F. V. Hartel, M. Aslam, Y. Abdallah, M. Schafer, H. M. Piper, T. Noll, and C. Schafer
Accumulation of extracellular ATP protects against acute reperfusion injury in rat heart endothelial cells
Cardiovasc Res,
September 1, 2006;
71(4):
764 - 773.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. A. Kruglov, R. A. Nathanson, T. Nguyen, and J. A. Dranoff
Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts
Am J Physiol Gastrointest Liver Physiol,
April 1, 2006;
290(4):
G765 - G771.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Burnstock
Pathophysiology and therapeutic potential of purinergic signaling.
Pharmacol. Rev.,
March 1, 2006;
58(1):
58 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Vekaria, D. G. Shirley, J. Sevigny, and R. J. Unwin
Immunolocalization of ectonucleotidases along the rat nephron
Am J Physiol Renal Physiol,
February 1, 2006;
290(2):
F550 - F560.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. McIlroy, M. O'Rourke, S. R. McKeown, D. G. Hirst, and T. Robson
Pericytes influence endothelial cell growth characteristics: Role of plasminogen activator inhibitor type 1 (PAI-1)
Cardiovasc Res,
January 1, 2006;
69(1):
207 - 217.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Machida, P. M. Heerdt, A. C. Reid, U. Schafer, R. B. Silver, M. J. Broekman, A. J. Marcus, and R. Levi
Ectonucleoside Triphosphate Diphosphohydrolase1/CD39, Localized in Neurons of Human and Porcine Heart, Modulates ATP-Induced Norepinephrine Exocytosis
J. Pharmacol. Exp. Ther.,
May 1, 2005;
313(2):
570 - 577.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. K. Kishore, J. Isaac, M. Fausther, S. R. Tripp, H. Shi, P. S. Gill, N. Braun, H. Zimmermann, J. Sevigny, and S. C. Robson
Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling
Am J Physiol Renal Physiol,
May 1, 2005;
288(5):
F1032 - F1043.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Furukoji, M. Matsumoto, A. Yamashita, H. Yagi, Y. Sakurai, K. Marutsuka, K. Hatakeyama, K. Morishita, Y. Fujimura, S. Tamura, et al.
Adenovirus-Mediated Transfer of Human Placental Ectonucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation In Vitro and Arterial Thrombus Formation In Vivo
Circulation,
February 15, 2005;
111(6):
808 - 815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Alvarado-Castillo, T. K. Harden, and J. L. Boyer
Regulation of P2Y1 Receptor-Mediated Signaling by the Ectonucleoside Triphosphate Diphosphohydrolase Isozymes NTPDase1 and NTPDase2
Mol. Pharmacol.,
January 1, 2005;
67(1):
114 - 122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Dranoff, M. Ogawa, E. A. Kruglov, M. D. A. Gaca, J. Sevigny, S. C. Robson, and R. G. Wells
Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells
Am J Physiol Gastrointest Liver Physiol,
August 1, 2004;
287(2):
G417 - G424.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kittel, J. Pelletier, F. Bigonnesse, O. Guckelberger, K. Kordas, N. Braun, S. C. Robson, and J. Sevigny
Localization of Nucleoside Triphosphate Diphosphohydrolase-1 (NTPDase1) and NTPDase2 in Pancreas and Salivary Gland
J. Histochem. Cytochem.,
July 1, 2004;
52(7):
861 - 871.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. la Sala, D. Ferrari, F. Di Virgilio, M. Idzko, J. Norgauer, and G. Girolomoni
Alerting and tuning the immune response by extracellular nucleotides
J. Leukoc. Biol.,
March 1, 2003;
73(3):
339 - 343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Krotz, H. Y. Sohn, M. Keller, T. Gloe, S. S. Bolz, B. F. Becker, and U. Pohl
Depolarization of Endothelial Cells Enhances Platelet Aggregation Through Oxidative Inactivation of Endothelial NTPDase
Arterioscler Thromb Vasc Biol,
December 1, 2002;
22(12):
2003 - 2009.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Vlajkovic, P. R. Thorne, J. Sevigny, S. C. Robson, and G. D. Housley
NTPDase1 and NTPDase2 Immunolocalization in Mouse Cochlea: Implications for Regulation of P2 Receptor Signaling
J. Histochem. Cytochem.,
November 1, 2002;
50(11):
1435 - 1442.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
